Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms.

Pergolini, I; Jäger, C; Safak, O; Göß, R; Novotny, A; Ceyhan, GÜRALP; Friess, H; Demir, IE

doi:10.1016/j.cgh.2020.04.090

Diabetes and Weight Loss Are Associated With Malignancies in Patients With Intraductal Papillary Mucinous Neoplasms.

Pergolini I., Jäger C., Safak O., Göß R., Novotny A., Ceyhan G., ...Daha Fazla

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, cilt.19, ss.171-179, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.cgh.2020.04.090
Dergi Adı: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
Sayfa Sayıları: ss.171-179
Anahtar Kelimeler: Metabolic Disorders, IPMN, Malignant Progression, RISK-FACTORS, PANCREAS, PROGRESSION, GUIDELINES, MANAGEMENT, PREDICTORS, DIAGNOSIS, MELLITUS, DUCT, IPMN
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

BACKGROUND & AIMS: The role of diabetes in intraductal papillary mucinous neoplasms (IPMNs) is not known. We investigated the prevalence of diabetes among patients with resected IPMNs and the association between diabetes, clinical and morphological features, and high-grade dysplasia or invasive cancer.